NOTE 4- RELATED PARTY TRANSACTIONS

Wellgistics Health and Tollo Health

On November 21, 2023, but effective September 14, 2023, the Company issued a promissory note (the “Wellgistics Note”) to Wellgistics Health, Inc. (f/k/a Danam Health Inc.) (“Wellgistics”) in the amount of $300,000. The Company prepaid $250,000 prior to the execution date. The Wellgistics Note did not accrue interest. As of December 31, 2023, the balance of the Wellgistics Note was $50,000. The Wellgistics Note was fully paid off in February 2024.

As of March 31, 2025, other receivables included a $3,828,769 receivable from Wellgistics and $215,000 receivable from Tollo. The receivables were unsecured, non-interest bearing and due on demand. The receivables were maintained by the Company’s former IPS subsidiary, which was sold to Tollo as of April 30, 2025.

On April 30, 2025, the Company completed the sale of its subsidiaries, IPS, Softell, and Bonum Health, Inc. to Tollo in exchange for a $5,000,000 promissory note bearing interest at the prime rate and maturing on June 30, 2030. The note requires Tollo to repay 20% of any future equity financing proceeds toward the outstanding balance. In connection with the transaction, the Company recorded a $5,000,000 promissory note receivable, and derecognized subsidiaries’ accounts payable of $117,162, other receivables of $4,219,239, operating lease right-of-use assets of $142,138, operating lease liability of $158,687 and a related party note receivable of $1,300,000. As such, the Company recognized a loss on disposition of $385,528. On June 24, 2025, the promissory note was assigned by Tollo to Integral Health, Inc. In August 2025, Integral Health, including its subsidiary IPS, were acquired by third parties. Therefore, as of December 31, 2025, Integral Health and Tollo is no longer considered a related party. As of December 31, 2025, the note receivable was outstanding and the Company recognized $250,000 in interest income, which was reclassified from note receivable, related party to note receivable on the consolidated balance sheet.

See Note 6 for detail on the note receivable from Wood Sage, LLC.

Suren Ajjarapu, the Company’s former Chief Executive Officer, and Prashant Patel, the Company’s former President and Chief Operating Officer, each had a beneficial interest in Tollo as of June 30, 2025. In August 2025, Integral Health, including its subsidiary IPS, were acquired by third parties. Therefore, at December 31, 2025, Integral Health and Tollo was no longer considered a related party.

Scienture Management

In July 2024, the executives of Scienture issued short-term loans to Scienture for an aggregate amount of $265,000. The loans were unsecured, interest bearing at the minimum applicable federal rate per annum, and due on demand. The loans were fully repaid in October 2025. Consequently, there were no amounts outstanding under these loan agreements as of December 31, 2025.

In November 2024, an executive of Scienture issued a short-term loan to Scienture for $150,000. The loan was unsecured, interest bearing at the minimum applicable federal rate per annum, and due on demand. The loan was fully repaid in October 2025. Consequently, there were no amounts outstanding under these loan agreements as of December 31, 2025.

In February 2025, an executive of Scienture issued a short-term loan to Scienture for $100,000. The loan was unsecured, interest bearing at the minimum applicable federal rate per annum, and due on demand. The loans were fully repaid in October 2025. Consequently, there were no amounts outstanding under these loan agreements as of December 31, 2025.

In February 2025, an executive of Scienture issued a short-term loan to Scienture for $16,000. The loan was unsecured, interest bearing at the minimum applicable federal rate per annum, and due on demand. The loan was fully repaid in October 2025. Consequently, there were no amounts outstanding under these loan agreements as of December 31, 2025.